Medical specialists from Pakistan tagged as investigators in clinical trials studying Purpura, Thrombocytopenic

Total 5 results

Andleeb Hanif, M.Phil
Seen in:
- Punjab, Rawalpindi, Armed Forces Bone Marrow Transplant Centre
Trials:
- NCT02877212 (Sub-Investigator)
Conditions:
- Immune Thrombocytopenic Purpura (ITP)
Kamran Mehmood, FCPS
Seen in:
- Punjab, Rawalpindi, Armed Forces Bone Marrow Transplant Centre
Trials:
- NCT02877212 (Sub-Investigator)
Conditions:
- Immune Thrombocytopenic Purpura (ITP)
Parvez Ahmed, FCPS, MCPS
Seen in:
- Punjab, Rawalpindi, Armed Forces Bone Marrow Transplant Centre
Trials:
- NCT02877212 (Principal Investigator)
Conditions:
- Immune Thrombocytopenic Purpura (ITP)
Qamar Un Nisa Ch, FCPS
Seen in:
- Punjab, Rawalpindi, Armed Forces Bone Marrow Transplant Centre
Trials:
- NCT02877212 (Sub-Investigator)
Conditions:
- Immune Thrombocytopenic Purpura (ITP)
Tariq M Satti, FCPS
Seen in:
- Punjab, Rawalpindi, Armed Forces Bone Marrow Transplant Centre
Trials:
- NCT02877212 (Sub-Investigator)
Conditions:
- Immune Thrombocytopenic Purpura (ITP)

Clinical Trials on Purpura, Thrombocytopenic

Turkish Hematology Association
Sanofi

Recruiting

Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study

TTP - Thrombotic Thrombocytopenic Purpura

Turkey
University of Cologne

Recruiting

Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (PREDICT2020)

Acquired Thrombotic Thrombocytopenic Purpura

Germany
Peking Union Medical College Hospital

Not yet recruiting

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Thrombotic Thrombocytopenic Purpura, Acquired

China
Fundación Española de Hematología y Hemoterapía

Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

Acquired Thrombotic Thrombocytopenic Purpura

Spain, Portugal
Takeda

Available

Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Thrombotic Thrombocytopenic Purpura (TTP)
Ablynx, a Sanofi company

Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (TITAN)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, France, Germany, Israel, Italy, Spain, Switzerland, United Kingdom, Bulgaria, Romania, Australia
Sanofi

Completed

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Thrombotic Thrombocytopenic Purpura

Japan
Sanofi

Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; Mach Gaensslen Foundation; Baxalta Innovations...

Recruiting

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) (TTP registry)

Thrombotic Thrombocytopenic Purpura | Congenital Thrombotic Thrombocytopenic Purpura | Familial Thrombotic Thrombocytopenic Purpura | Thrombotic Thrombocytopenic Purpura, Congenital | Upshaw-Schulman Syndrome

United States, Austria, Czechia, Germany, Japan, Norway, Switzerland
University of Cologne

Recruiting

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP (REACT-2020)

Acquired Thrombotic Thrombocytopenic Purpura

Germany

Medical specialists from Pakistan tagged as investigators in clinical trials studying Purpura, Thrombocytopenic

Clinical Trials on Purpura, Thrombocytopenic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations